KiraGen

KiraGen Bio

This biotechnology company develops gene-edited cell therapies to treat solid tumours for patients with glioblastoma and other cancers.

Trogenix

Trogenix develops precision gene therapies and synthetic super-enhancers for patients with aggressive solid tumours, including glioblastoma and colorectal cancer liver metastases.

Kindling Bio

This company develops a gene therapy platform that engineers tumour cells to display markers for the immune system to treat children with solid tumours.

Siren Bio

This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.

QuirieGen

This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.

T-CURX

This biotech company develops non-viral CAR-T cell therapies to treat patients with leukaemia, lymphoma and solid tumours.

Eigen Therapeutics

The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.

NovalGen

NovalGen develops multi-specific antibody therapies and self-regulating immunotherapies for patients with oncology, autoimmune, haematological, and metabolic disorders.